Of the three, two showed
improvement, while a third, who also had bearded hemangioma, required tracheotomy.
Discussion: Infantile subglottic hemangiomas are rare but essential in the differential diagnosis of biphasic stridor. Although propranolol has been selleck products effective in treating cutaneous and airway hemangiomas, our experience suggests that this is not consistent for subglottic hemangiomas. In an area where airway compromise can be lethal, we must extend caution and monitor these patients closely as they may require adjuvant therapy. (C) 2011 Elsevier Ireland Ltd. All rights reserved.”
“The aim of this study is to evaluate the effectiveness of the low-level laser therapy (LLLT) in the control of pain, swelling, and trismus associated with surgical removal of impacted lower third molars. Thirty patients were randomized into two treatment groups, each with 15 patients-group test (LLLT) and a group control
(no-LLLT)-and were told to avoid any analgesics 12 h before the procedure. In group test, the 980-nm diode-laser (G-Laser 25 Galbiati, Italy) was applied, using a 600-mu m handpiece, intraorally (lingual and vestibular) at 1 cm from the involved area and extraoral at the insertion point of the masseter muscle immediately after surgery and at 24 h. The group control received only routine management. Parameters used for LLLT were: continuous mode, at 300 mW (0.3 W) for a total of 180 s (60 s x 3) (0.3 W x 180 s = 54 J). Group test showed improvement in the interincisal find more opening and remarkable reduction of trismus, swelling ARN-509 Endocrinology & Hormones inhibitor and intensity of pain on the first and the seventh postoperative days. Although LLLT has been reported to prevent
swelling and trismus following the removal of impacted third molars, some of these studies reported a positive laser effect while others did not. All references to the use of laser therapy in the postoperative management of third molar surgery employ different methodologies and, in some, explanations as to selection of their respective radiation parameters are not given. This study has demonstrated that LLLT, with these parameters, is useful for the reduction of postoperative discomfort after third-molar surgery.”
“Plants from the genus Erica are used in many countries to treat several ailments. In this work we intend to evaluate the potential in vivo benefits of Erica australis L. by testing in vitro the effect induced by the plant extract when in contact with BJ fibroblasts (3 and 6 h) and Caco-2 cells (3,6 and 24 h). Effects on five pathogenic microorganisms (Enterococcus faecalis, Bacillus cereus, Escherichia coli, Staphylococcus aureus and Listeria monocytogenes) were also determined. It was found that the extracts enhanced fibroblast proliferation (maximum of 484% of control at 6 h exposure) while Caco-2 cells viability was reduced in a concentration and time dependent manner (minimum of 22.3% of control at 24 h exposure).